NSTEMI Clinical Trial - The Problem of Incomplete Myocardial

Status Completed

Clinical Trial Summary

The study included all patients admitted to the intensive care unit of the district hospital and sent to the angiographic Department for diagnosis and performance of PCI with a diagnosis of NSTEMI, including myocardial infarction (mi) and unstable angina, determined by clinical data, ECG signs and laboratory indicators. Data from patients living in the Sergiev Posad municipal district will be analyzed in order to achieve maximum registration of adverse events during one year of follow-up.

Clinical Trial Description

Objective: to investigate the problem of incomplete myocardial revascularization in percutaneous coronary interventions in patients with acute coronary syndrome without St segment elevation who were admitted to the angiographic Department of the Sergiev Posad city hospital in the Moscow region.

The study will include all patients admitted to the intensive care unit of the regional hospital and sent to the angiographic Department for diagnosis and performance of PCI with acute coronary syndrome NSTEMI, including myocardial infarction (mi) and unstable angina, determined by clinical data, ECG signs and laboratory indicators. Anamnestic, clinical, biochemical indicators, cardiovascular risk factors, comorbid index that determines the course of acute coronary syndrome and prognosis (grace), a number of angiographic data, including the number of affected arteries and variants of the index "syntax score 50" and modified "syntax score 30", "syntax score 70" and" syntax score 90" to separate complete and incomplete revascularization, an integral indicator of the quality of the remaining index Syntex, the absolute value of which is corrected during data analysis. The data of patients living in the city of Sergiev Posad will be reviewed in such a way as to minimize the subsequent year of follow-up, using a telephone survey and the EMIAS electronic system ;

Study Design

Related Conditions & MeSH terms

Non-ST Elevated Myocardial Infarction
NSTEMI

Clinical Trial Details

NCT number	NCT04490928
Study type	Observational
Source	National Medical Research Center for Therapy and Preventive Medicine
Contact
Status	Completed
Phase
Start date	November 1, 2018
Completion date	July 28, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02871622` - BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM	N/A
Recruiting	`NCT02748603` - Appropriateness of Coronary Angioplasty in PAtients With isCHEmic Heart Disease	N/A
Active, not recruiting	`NCT01433627` - Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX	Phase 3
Completed	`NCT01197742` - Sweetheart-Register: Risk Management of Diabetics With Acute Myocardial Infarction	N/A
Completed	`NCT01634425` - Providing Rapid Out of Hospital Acute Cardiovascular Treatment (PROACT)	Phase 4
Not yet recruiting	`NCT00774475` - Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition	Phase 3
Active, not recruiting	`NCT04900155` - Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19	N/A
Completed	`NCT04861519` - Pivotal, Single-arm Clinical Trial to Assess the Efficacy and Safety of the MedHub AutocathFFR Software Device
Not yet recruiting	`NCT06404515` - Telehealth Group Counseling and Preventive Care for Women	N/A
Not yet recruiting	`NCT05263778` - Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study	Phase 4
Withdrawn	`NCT02095522` - COlchicine Improve EnDothElial Function in Non ST Elevation Myocardial Infarction Patients	N/A
Recruiting	`NCT05764057` - DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction	Phase 3
Enrolling by invitation	`NCT05800951` - Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
Completed	`NCT01159366` - Incidence of Occluded Culprit Arteries and Impact of Coronary Collaterals on Outcome in Patients With NSTEMI	Phase 4
Completed	`NCT04270630` - A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI	N/A
Withdrawn	`NCT05957172` - Mobile Advanced Multi-Parameter Reporting in Patients Wearing a Novel Device: Utilization During Cardiac Rehabilitation
Completed	`NCT01543373` - Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS	N/A
Active, not recruiting	`NCT05175261` - Assessment of Individual Risk of Cardiovascular Events by Platelet FcGammaRIIa
Recruiting	`NCT04824001` - Exercise Echocardiography on LV Mechanics in Patients With CAD: a Speckle-tracking Echocardiography
Recruiting	`NCT04988672` - OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting With Acute MyocaRdial Infarction

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Problem of Incomplete Myocardial Revascularization in Percutaneous Coronary Intervention in Patients With NSTEMI — CONTRAST

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms